Movement Alert｜CSPC PHARMA Rises 3.22% in Regular Trading, Innovative Pharma Sector Strengthens as AstraZeneca Payments Confirmed

Market Focus

Aug 17

On August 17, CSPC PHARMA rose 3.22% in regular trading, trading at HKD 8.965 per share, with turnover of HKD 371 million.

On the news front, Hong Kong-listed innovative pharmaceutical stocks collectively strengthened during the session, with HUTCHMED up over 7% and WuXi Biologics up over 5%, providing broad sector tailwinds for CSPC PHARMA. Additionally, the company recently confirmed receipt of a USD 30 million upfront payment from AstraZeneca on August 12 under their siRNA drug collaboration agreement signed in July, and a separate USD 10 million milestone payment on August 5 under a small-molecule research collaboration dating from June 2025. The accelerating pace of international partnership monetization has bolstered investor sentiment.

Within the Pharmaceuticals sector, HENGRUI PHARMA up 2.75%, HUTCHMED up 5.89%, ASYMCHEM up 6.91%, SBP GROUP up 1.36%, HANSOH PHARMA flat.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/news/1185904791"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1185904791\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1185904791?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-17 11:13","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1185904791","market":"us","top_or_hot":-1,"title":"Movement Alert｜CSPC PHARMA Rises 3.22% in Regular Trading, Innovative Pharma Sector Strengthens as AstraZeneca Payments Confirmed","media":"Market Focus","content":"<p><p>On August 17, CSPC PHARMA rose 3.22% in regular trading, trading at HKD 8.965 per share, with turnover of HKD 371 million.</p><p>On the news front, Hong Kong-listed innovative pharmaceutical stocks collectively strengthened during the session, with HUTCHMED up over 7% and WuXi Biologics up over 5%, providing broad sector tailwinds for CSPC PHARMA. Additionally, the company recently confirmed receipt of a USD 30 million upfront payment from AstraZeneca on August 12 under their siRNA drug collaboration agreement signed in July, and a separate USD 10 million milestone payment on August 5 under a small-molecule research collaboration dating from June 2025. The accelerating pace of international partnership monetization has bolstered investor sentiment.</p><p>Within the Pharmaceuticals sector, HENGRUI PHARMA up 2.75%, HUTCHMED up 5.89%, ASYMCHEM up 6.91%, SBP GROUP up 1.36%, HANSOH PHARMA flat.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜CSPC PHARMA Rises 3.22% in Regular Trading, Innovative Pharma Sector Strengthens as AstraZeneca Payments Confirmed</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜CSPC PHARMA Rises 3.22% in Regular Trading, Innovative Pharma Sector Strengthens as AstraZeneca Payments Confirmed\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-17 11:13</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 17, CSPC PHARMA rose 3.22% in regular trading, trading at HKD 8.965 per share, with turnover of HKD 371 million.</p><p>On the news front, Hong Kong-listed innovative pharmaceutical stocks collectively strengthened during the session, with HUTCHMED up over 7% and WuXi Biologics up over 5%, providing broad sector tailwinds for CSPC PHARMA. Additionally, the company recently confirmed receipt of a USD 30 million upfront payment from AstraZeneca on August 12 under their siRNA drug collaboration agreement signed in July, and a separate USD 10 million milestone payment on August 5 under a small-molecule research collaboration dating from June 2025. The accelerating pace of international partnership monetization has bolstered investor sentiment.</p><p>Within the Pharmaceuticals sector, HENGRUI PHARMA up 2.75%, HUTCHMED up 5.89%, ASYMCHEM up 6.91%, SBP GROUP up 1.36%, HANSOH PHARMA flat.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01093","symbol_name":"石药集团","start_time":0,"source_url":"","article_id":"1185904791","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1185904791","pubTimestamp":1786936400,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 17, CSPC PHARMA rose 3.22% in regular trading, trading at HKD 8.965 per share, with turnover of HKD 371 million.On the news front, Hong Kong-listed innovative pharmaceutical stocks...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01093":"石药集团"},"translate_title":"走势提醒|石药集团常规交易上涨3.22%，阿斯利康付款确认，创新制药板块走强","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01093":1},"content_text":"On August 17, CSPC PHARMA rose 3.22% in regular trading, trading at HKD 8.965 per share, with turnover of HKD 371 million.On the news front, Hong Kong-listed innovative pharmaceutical stocks collectively strengthened during the session, with HUTCHMED up over 7% and WuXi Biologics up over 5%, providing broad sector tailwinds for CSPC PHARMA. Additionally, the company recently confirmed receipt of a USD 30 million upfront payment from AstraZeneca on August 12 under their siRNA drug collaboration agreement signed in July, and a separate USD 10 million milestone payment on August 5 under a small-molecule research collaboration dating from June 2025. The accelerating pace of international partnership monetization has bolstered investor sentiment.Within the Pharmaceuticals sector, HENGRUI PHARMA up 2.75%, HUTCHMED up 5.89%, ASYMCHEM up 6.91%, SBP GROUP up 1.36%, HANSOH PHARMA flat.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}